Patents by Inventor Axelle Samson

Axelle Samson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7220740
    Abstract: Compound corresponding to the general formula (I) in which X represents an oxygen or sulphur atom or an NH group and R1, R2, R3 and R4 each represent a hydrogen or halogen atom or a nitro, amino, trifluoromethyl, trifluoroalkoxy, cyano, hydroxyl, (C1–C6)alkyl, (C1–C6)alkoxy or phenyl group. Application in therapeutics.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: May 22, 2007
    Assignee: Sanofi-aventis
    Inventors: Frédéric Galli, Alistair Lochead, Axelle Samson
  • Patent number: 6908927
    Abstract: The invention relates to pyridopyranoazepine derivatives, to pharmaceutical compositions containing them, to process for preparing them, and to the method of use thereof in the treatment or prevention of disorders associated with a dysfunction of the nicotine receptors.
    Type: Grant
    Filed: February 6, 2003
    Date of Patent: June 21, 2005
    Assignee: Sanofi-Synthelabo
    Inventors: Frédéric Galli, Samir Jegham, Alistair Lochead, Axelle Samson
  • Publication number: 20030187012
    Abstract: The invention relates to pyridopyranoazepine derivatives, to pharmaceutical compositions containing them, to process for preparing them, and to the method of use thereof in the treatment or prevention of disorders associated with a dysfunction of the nicotine receptors.
    Type: Application
    Filed: February 6, 2003
    Publication date: October 2, 2003
    Inventors: Frederic Galli, Samir Jegham, Alistair Lochead, Axelle Samson
  • Publication number: 20030153574
    Abstract: Compound corresponding to the general formula (I) 1
    Type: Application
    Filed: February 24, 2003
    Publication date: August 14, 2003
    Inventors: Frederic Galli, Alistair Lochead, Axelle Samson
  • Patent number: 6538003
    Abstract: The invention relates to pyridopyranoazepine derivatives, to pharmaceutical compositions containing them, to processes for preparing them, and to the method of use thereof in the treatment or prevention of disorders associated with a dysfunction of the nicotine receptors.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: March 25, 2003
    Assignee: Sanofi-Synthelabo
    Inventors: Frédéric Galli, Samir Jegham, Alistair Lochead, Axelle Samson
  • Patent number: 6255319
    Abstract: Compound of general formula (I) in which R1 represents an alkyl or cycloalkylmethyl group, X1 represents a hydrogen or halogen atom or an alkoxy group, or alternatively OR1 and X1 together represent an —OCH2O—, —O(CH2)2—, —O(CH2)3—, —O(CH2)2O— or —(CH2)3O— group, X2 represents a hydrogen atom or an amino group, X3 represents a hydrogen or halogen atom, and R2 represents a hydrogen atom, an optionally substituted alkyl group, an optionally substituted phenylalkyl group or a group —(CH2)nCO—Z in which n represents a number from 1 to 6 and Z represents a 1-piperidyl group. Therapeutic application.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: July 3, 2001
    Assignee: Sanofi-Synthelabo
    Inventors: Samir Jegham, Alistair Lochead, Frédéric Galli, Alain Nedelec, Axelle Samson, Thierry Gallet